• Form 4 Contineum Therapeutics Inc For: 10 July By Investing.com Investing.com Nigeria Fri, 10 Jul 2026 22:26:47 GMT
• Contineum Therapeutics CSO Lorrain Daniel S. sells $16,640 in stock By Investing.com Investing.com UK Fri, 10 Jul 2026 21:26:00 GMT
• Contineum Therapeutics (NASDAQ: CTNM) CSO sells 1,040 shares, exercises options Stock Titan Fri, 10 Jul 2026 21:21:05 GMT
• Are You Looking for a Top Momentum Pick? Why Contineum Therapeutics, Inc. (CTNM) is a Great Choice Yahoo Finance Thu, 09 Jul 2026 16:00:04 GMT
• form 4 contineum therapeutics inc for: 8 july by investing.com Investing.com Nigeria Thu, 09 Jul 2026 00:26:24 GMT
• Contineum Therapeutics CEO Stengone sells $40,000 in shares By Investing.com Investing.com Nigeria Wed, 08 Jul 2026 23:33:40 GMT
• Price to sales forward of Contineum Therapeutics, Inc. – NASDAQ:CTNM TradingView Wed, 08 Jul 2026 23:09:04 GMT
• Form 4 Contineum Therapeutics Inc For: 8 July By Investing.com Investing.com India Wed, 08 Jul 2026 22:58:27 GMT
• Contineum (CTNM) CEO sells 2,500 shares under Rule 10b5-1 plan Stock Titan Wed, 08 Jul 2026 22:49:44 GMT
• Form 144 Contineum Therapeutics For: 8 July By Investing.com Investing.com Nigeria Wed, 08 Jul 2026 21:12:39 GMT
• CTNM insider selling 2,500 shares via option exercise; prior 10,000-share 10b5-1 sale Stock Titan Wed, 08 Jul 2026 20:40:04 GMT
• enterprise value to revenue forward of contineum therapeutics, inc. – nasdaq:ctnm TradingView Wed, 08 Jul 2026 02:53:36 GMT
• CTNM Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Continued Clinical Progress - Estimate Uncertainty dars.gov.et Mon, 06 Jul 2026 09:47:26 GMT
• Contineum Therapeutics CSO Daniel Lorrain sells $594,578 in stock By Investing.com Investing.com South Africa Fri, 03 Jul 2026 00:03:54 GMT
• Contineum Therapeutics CSO Daniel Lorrain sells $594,578 in stock By Investing.com Investing.com Nigeria Thu, 02 Jul 2026 22:10:51 GMT
• form 4 contineum therapeutics inc for: 2 july by investing.com Investing.com Canada Thu, 02 Jul 2026 22:03:16 GMT
• Contineum (NASDAQ: CTNM) CSO sells 37,179 shares and exercises 33,009 options Stock Titan Thu, 02 Jul 2026 07:00:00 GMT
• Contineum Therapeutics CMO Tim Watkins sells $173,590 in company stock Investing.com Wed, 01 Jul 2026 23:33:32 GMT
• Form 4 Contineum Therapeutics Inc For: 1 July By Investing.com Investing.com India Wed, 01 Jul 2026 23:17:50 GMT
• Contineum Therapeutics CEO Stengone sells $160,080 in stock By Investing.com Investing.com Canada Wed, 01 Jul 2026 23:11:48 GMT
• [Form 4] Contineum Therapeutics, Inc. Insider Trading Activity Stock Titan Wed, 01 Jul 2026 23:04:46 GMT
• form 144 contineum therapeutics for: 1 july by investing.com Investing.com Canada Wed, 01 Jul 2026 20:47:06 GMT
• Insider sales and option exercise at CTNM (NASDAQ: CTNM) Stock Titan Wed, 01 Jul 2026 20:35:06 GMT
• Contineum (NASDAQ: CTNM) CMO sells 10,833 shares after option exercise Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• contineum therapeutics publishes discovery of potential best-in-class lpar1 antagonist pipe-791 in journal of medicinal chemistry BioSpace Wed, 01 Jul 2026 04:03:30 GMT
• form 144 contineum therapeutics for: 30 june by investing.com Investing.com Nigeria Tue, 30 Jun 2026 22:36:18 GMT
• contineum publishes manuscript on pipe-791 in journal of medicinal chemistry TipRanks Tue, 30 Jun 2026 21:07:53 GMT
• Contineum publishes discovery data on LPAR1 antagonist PIPE-791 By Investing.com Investing.com Canada Tue, 30 Jun 2026 20:24:40 GMT
• Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry Business Wire Tue, 30 Jun 2026 07:00:00 GMT
• CTNM (NASDAQ) notice to sell 28,826 shares; broker Morgan Stanley named Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 07:00:00 GMT
• Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to Russell 2000 Dynamic Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Contineum Therapeutics, Inc.(NasdaqGS:CTNM) added to Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Contineum Stockholders Hold 2026 Virtual Annual Meeting The Globe and Mail Sat, 27 Jun 2026 07:00:00 GMT
• form 4 contineum therapeutics inc for: 26 june by investing.com Investing.com Nigeria Sat, 27 Jun 2026 03:33:31 GMT
• form 4 contineum therapeutics inc for: 26 june by investing.com Investing.com Canada Fri, 26 Jun 2026 21:52:14 GMT
• contineum therapeutics (ctnm) awards director 19,000-share stock option grant Stock Titan Fri, 26 Jun 2026 21:45:24 GMT
• [Form 4] Contineum Therapeutics, Inc. Insider Trading Activity Stock Titan Fri, 26 Jun 2026 21:44:20 GMT
• contineum therapeutics, inc. class a actuals & estimates (nasdaq:ctnm) TradingView Fri, 26 Jun 2026 08:19:36 GMT
• Contineum Therapeutics (CTNM) elects Class II directors, ratifies Ernst & Young as 2026 auditor Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Contineum Therapeutics (CTNM) grants director 19,000 stock options at $14.19 Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Contineum (CTNM) awards non-employee director 19,000 stock options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Contineum Therapeutics (CTNM) director receives 19,000 stock options grant Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• Contineum Therapeutics (NASDAQ: CTNM) grants director 19,000 stock options Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• contineum therapeutics inc (ctnm) valuation: pe, pb & fair value analysis TradingKey Fri, 26 Jun 2026 02:22:13 GMT
• contineum therapeutics inc (ctnm) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• jonestrading maintains contineum therapeutics(ctnm.us) with buy rating, maintains target price $26 富途牛牛 Sat, 20 Jun 2026 23:26:08 GMT
• CTNM Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise - Forward Guidance Trends dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• contineum therapeutics inc (ctnm) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 10:21:14 GMT
• contineum therapeutics inc (ctnm) institutional confidence TradingKey Thu, 18 Jun 2026 10:20:32 GMT
• contineum therapeutics inc (ctnm) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 10:20:30 GMT
• contineum therapeutics inc (ctnm) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 10:19:44 GMT
• contineum therapeutics inc (ctnm) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 10:17:15 GMT
• contineum therapeutics inc (ctnm) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:51:59 GMT
• contineum therapeutics inc (ctnm) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:56:52 GMT
• contineum therapeutics inc (ctnm) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:48:32 GMT
• contineum therapeutics (ctnm) slides 2.44% as resistance holds firm - intraday trade ideas newsline.com Tue, 16 Jun 2026 15:34:17 GMT
• number of shareholders of contineum therapeutics, inc. – nasdaq:ctnm TradingView Tue, 16 Jun 2026 09:24:40 GMT
• contineum therapeutics inc (ctnm) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• CTNM Q1 2026 Earnings: Narrower Loss Surprises as Pipeline Advances - Performance Review dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• ctnm q1 2026 earnings: narrower-than-expected loss surprises markets - quarterly profit report dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• ctnm: pipe-791 advances in ipf with best-in-class potential, strong safety, and robust clinical momentum TradingView Tue, 09 Jun 2026 18:36:21 GMT
• CTNM: PIPE-791 advances in IPF with strong differentiation, robust pipeline, and solid financial runway TradingView Tue, 09 Jun 2026 07:00:00 GMT
• ctnm q1 2026 earnings: -$0.39 eps beats expectations by 28%, but stock declines 6.89% amid pre-revenue quarter - guidance revision... newsline.com Sun, 07 Jun 2026 07:46:21 GMT
• contineum therapeutics (ctnm) holds steady near support as low volume suggests investor caution - rvol spike dars.gov.et Thu, 04 Jun 2026 07:00:00 GMT
• contineum therapeutics cso daniel lorrain sells $54,862 in stock Investing.com Tue, 02 Jun 2026 00:26:33 GMT
• Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• Contineum Therapeutics CSO Daniel Lorrain sells $54,862 in stock Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• contineum therapeutics (ctnm) cso sells 4,170 shares under 10b5-1 plan Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ctnm insider 10b5-1 sales recorded by morgan stanley (ctnm) Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ctnm q1 2026 earnings: narrower-than-expected loss as clinical pipeline advances - earnings turnaround newsline.com Fri, 29 May 2026 07:00:00 GMT
• contineum therapeutics, inc. - common stock (ctnm) stock price, news, quote & history FinancialContent Thu, 28 May 2026 20:38:00 GMT
• contineum therapeutics (ctnm) retreats 1.08% – key support level in focus - overbought signal alerts The Legal Advocate Thu, 28 May 2026 18:37:15 GMT
• contineum therapeutics inc. (ctnm) q1 2026 earnings: narrower loss beats expectations - earnings beat alert newsline.com Thu, 28 May 2026 07:00:00 GMT
• wall street analysts think contineum therapeutics, inc. (ctnm) could surge 49.21%: read this before placing a bet MSN Thu, 28 May 2026 06:08:19 GMT
• ctnm q1 2026 earnings: narrower loss beats estimates as pre-revenue biotech maintains discipline - interim report The Legal Advocate Wed, 27 May 2026 03:34:08 GMT
• Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High? Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
• contineum therapeutics (ctnm) declines 3.55%, testing key support at $13.17 - obv breakout dars.gov.et Mon, 25 May 2026 07:00:00 GMT
• contineum therapeutics inc. (ctnm) q1 2026 earnings: clinical-stage biotech reports narrower loss, shares dip - financial data newsline.com Mon, 25 May 2026 06:43:17 GMT
• ctnm q1 2026 earnings: narrower-than-expected loss drives strong eps surprise, but shares slip - expert market insights Newser Sun, 24 May 2026 15:38:42 GMT
• ctnm q1 2026 earnings: narrowed loss exceeds expectations as pipeline advances - pre-announcement alert newsline.com Sat, 23 May 2026 07:00:00 GMT
• contineum therapeutics, inc. - common stock (ctnm) stock price, news, quote & history FinancialContent Sat, 23 May 2026 00:10:00 GMT
• contineum therapeutics touts pipe-791 ipf focus as pain data hint at wider potential The Globe and Mail Fri, 22 May 2026 07:00:00 GMT
• ctnm q1 2026 earnings: significant eps beat amid pipeline progress, stock slightly down - earnings per share newsline.com Fri, 22 May 2026 07:00:00 GMT
• ctnm q1 2026 earnings: eps surprise beats estimates, stock rises amid r&d progress - tangible book value The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Sun, 17 May 2026 10:21:42 GMT
• contineum therapeutics reports inducement grant under nasdaq listing rule 5635(c)(4) - may 15, 2026 BioSpace Sun, 17 May 2026 07:00:00 GMT
• contineum therapeutics reports inducement grant under nasdaq listing rule 5635(c)(4) Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• balyasny group (ctnm) reports 2.42m shares via admf, ~7.40% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ra capital affiliates report 1.296m shares of contineum (ctnm) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• are medical stocks lagging c4 therapeutics (cccc) this year? Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• morgan stanley raises price target on contineum therapeutics to $16 from $14, keeps equalweight rating Moomoo Thu, 14 May 2026 11:58:58 GMT
• contineum therapeutics, inc. stock 12‑month price target raised to $22.33, implies 58% upside TradingView Thu, 14 May 2026 07:00:00 GMT
• morgan stanley maintains contineum therapeutics(ctnm.us) with hold rating, raises target price to $16 Moomoo Thu, 14 May 2026 07:00:00 GMT
• contineum therapeutics to present at the 2026 rbc capital markets global healthcare conference BioSpace Wed, 13 May 2026 07:00:00 GMT
• stream contineum’s 2026 rbc global healthcare conference talk live Stock Titan Tue, 12 May 2026 07:00:00 GMT
• contineum therapeutics announces two upcoming posters at the american thoracic society (ats) 2026 international conference BioSpace Tue, 12 May 2026 07:00:00 GMT
• contineum therapeutics to present at the 2026 rbc capital markets global healthcare conference Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• stifel nicolaus remains a buy on contineum therapeutics, inc. class a (ctnm) The Globe and Mail Tue, 12 May 2026 02:48:00 GMT
• rbc capital maintains contineum therapeutics (ctnm) outperform recommendation MSN Mon, 11 May 2026 14:28:35 GMT
• Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference Business Wire Mon, 11 May 2026 07:00:00 GMT
• lung fibrosis study: pipe-791 reduces cell death in lab tests at ats 2026 Stock Titan Mon, 11 May 2026 07:00:00 GMT
• stifel nicolaus remains a buy on contineum therapeutics, inc. class a (ctnm) The Globe and Mail Mon, 11 May 2026 07:00:00 GMT
• contineum therapeutics, inc. (nasdaq:ctnm) receives consensus recommendation of "moderate buy" from brokerages MarketBeat Mon, 11 May 2026 06:17:42 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Sun, 10 May 2026 14:13:48 GMT
• wall street analysts think contineum therapeutics, inc. (ctnm) could surge 49.21%: read this before placing a bet MSN Sun, 10 May 2026 07:02:45 GMT
• rbc capital maintains contineum therapeutics (ctnm) outperform recommendation MSN Sun, 10 May 2026 03:26:24 GMT
• rbc capital maintains contineum therapeutics (ctnm) outperform recommendation MSN Sat, 09 May 2026 15:31:54 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar msn.com Sat, 09 May 2026 13:56:11 GMT
• analysts offer insights on healthcare companies: gilead sciences (gild), entrada therapeutics inc (trda) and contineum therapeutic... The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
• wall street analysts think contineum therapeutics, inc. (ctnm) could surge 49.21%: read this before placing a bet MSN Sat, 09 May 2026 04:14:42 GMT
• ctnm sec filings - contineum therapeutics 10-k, 10-q, 8-k forms Stock Titan Fri, 08 May 2026 18:05:13 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Fri, 08 May 2026 13:44:55 GMT
• wall street analysts think contineum therapeutics, inc. (ctnm) could surge 49.21%: read this before placing a bet Yahoo Finance Fri, 08 May 2026 07:00:00 GMT
• jonestrading maintains contineum therapeutics(ctnm.us) with buy rating, maintains target price $26 Moomoo Fri, 08 May 2026 07:00:00 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Thu, 07 May 2026 14:54:09 GMT
• analysts offer insights on healthcare companies: quidelortho (qdel), contineum therapeutics, inc. class a (ctnm) and schrodinger (... The Globe and Mail Thu, 07 May 2026 07:20:00 GMT
• analysts offer insights on healthcare companies: iqvia holdings (iqv), contineum therapeutics, inc. class a (ctnm) and exelixis (e... The Globe and Mail Thu, 07 May 2026 07:00:00 GMT
• contineum therapeutics, inc. q1 2026 financial report: earnings, clinical pipeline progress, and forward-looking statements 14 – m... Minichart Wed, 06 May 2026 07:00:00 GMT
• rbc capital maintains contineum therapeutics(ctnm.us) with buy rating, maintains target price $22 Moomoo Wed, 06 May 2026 07:00:00 GMT
• contineum therapeutics reports first-quarter 2026 financial results; affirms key clinical development milestones BioSpace Wed, 06 May 2026 06:20:45 GMT
• contineum therapeutics sees funding sufficient through mid-2029 >ctnm Moomoo Tue, 05 May 2026 20:52:00 GMT
• contineum therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 05 May 2026 20:05:00 GMT
• contineum therapeutics reports inducement grant under nasdaq listing rule 5635(c)(4) Quantisnow Tue, 05 May 2026 13:11:13 GMT
• Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones Business Wire Tue, 05 May 2026 07:00:00 GMT
• contineum therapeutics 1q 2026: net loss $(14.5)m, eps $(0.39) — 10-q summary TradingView Tue, 05 May 2026 07:00:00 GMT
• contineum (nasdaq: ctnm) q1 loss narrows, cash reaches $246.3m Stock Titan Tue, 05 May 2026 07:00:00 GMT
• chronic pain data and cash runway to 2029 for contineum (nasdaq: ctnm) Stock Titan Tue, 05 May 2026 07:00:00 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Tue, 05 May 2026 04:51:04 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar MSN Mon, 04 May 2026 14:36:02 GMT
• contineum therapeutics (nasdaq:ctnm) shares up 7.5% - time to buy? MarketBeat Mon, 04 May 2026 07:00:00 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar Sahm Sat, 02 May 2026 21:49:54 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Sat, 02 May 2026 01:44:00 GMT
• contineum's non-opioid pain drug shows promise in early trial BriefGlance Fri, 01 May 2026 09:18:31 GMT
• CTNM (NASDAQ: CTNM) affiliate reports multiple 10b5-1 sales by Daniel Lorrain Stock Titan Fri, 01 May 2026 07:00:00 GMT
• stifel maintains contineum therapeutics(ctnm.us) with buy rating, maintains target price $29 Moomoo Fri, 01 May 2026 07:00:00 GMT
• two new contineum hires receive 51,000-share stock options Stock Titan Fri, 01 May 2026 07:00:00 GMT
• contineum therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4) Yahoo Finance Fri, 01 May 2026 07:00:00 GMT
• contineum (nasdaq: ctnm) cso trims stake under 10b5-1 plan Stock Titan Fri, 01 May 2026 07:00:00 GMT
• contineum therapeutics cso daniel lorrain sells $54,694 in stock Investing.com Fri, 01 May 2026 07:00:00 GMT
• contineum therapeutics stock edges higher as pipe-791 pain data clears safety bar Benzinga Fri, 01 May 2026 07:00:00 GMT
Contineum Therapeutics Inc(:CTNM)
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule in...
Website: https://www.contineum-tx.com/
Founded: 2009
Share this website to your friends